Segmentation with artificial intelligence and automated calculation of the corpus callosum index in multiple sclerosis.
Journal:
Saudi medical journal
Published Date:
Jun 1, 2025
Abstract
OBJECTIVES: To determine the corpus callosum index (CCI) differences between chronic phase multiple sclerosis (MS) patients and healthy individuals and to evaluate the corpus callosum segmentation in MS patients using artificial intelligence technologies. The CCI can be reliably measured on magnetic resonance imaging (MRI) and has been proposed as a possible marker of brain atrophy in MS.